Kim L.R. Brouwer

Kim L.R. Brouwer serves as Interim Dean and William R. Kenan Jr. Distinguished Professor at the UNC Eshelman School of Pharmacy. Her research focuses on hepatobiliary drug disposition, drug transporters, and in vitro model systems for predicting drug interactions and hepatotoxicity. She co-invented B-CLEAR®, a patented in vivo/hepatocyte-based drug screening technology, and founded Qualyst, Inc. (acquired by BioIVT). Brouwer has mentored over 100 students and published 230+ peer-reviewed articles.

• Education: Pharm.D. and Ph.D. from University of Kentucky; B.S. in Pharmacy from Oregon State University
• Awards: ASCPT-FDA Abrams Award (2018), AACP Volwiler Award (2020), AAPS Fellow (1998)

Her lab investigates hepatic transporters in liver disease, precision medicine applications, and PFAS impacts on drug metabolism. Collaborations include NIH-funded projects on drug interactions and transporter dynamics. She chairs Qualyst’s scientific advisory board and contributes to FDA review panels.